Vrk1 — Vaccinia Related Kinase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about VRK1 Gene, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.
| Property | Value |
|---|---|
| Gene Symbol | VRK1 |
| Full Name | Vaccinia-Related Kinase 1 |
| Chromosomal Location | 14q32.33 |
| NCBI Gene ID | 7443 |
| OMIM ID | 604680 |
| Ensembl ID | ENSG00000100749 |
| UniProt ID | Q15818 |
| Associated Diseases | Hereditary Spastic Paraplegia, pontocerebellar hypoplasia, cancer |
VRK1 encodes a serine/threonine protein kinase belonging to the VRK (Vaccinia-Related Kinase) family. VRK1 is a nuclear kinase involved in multiple cellular processes including:
In neurons, VRK1 localizes to:
VRK1 is essential for neuronal migration and cortical development through phosphorylation of BAF, which regulates nuclear envelope breakdown and reassembly during neuronal progenitor division.
VRK1 mutations cause autosomal recessive hereditary spastic paraplegia type 31 (SPG31). Clinical features include:
Common VRK1 mutations include:
VRK1 mutations can also cause pontocerebellar hypoplasia type 1A (PCH1A), characterized by:
VRK1 is overexpressed in multiple cancers (breast, lung, gastric) and functions as an oncogene. It promotes:
VRK1 is expressed in:
Highest expression during fetal development and decreases in adulthood.
The study of Vrk1 — Vaccinia Related Kinase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Renbaum P, et al. (2009). VRK1 mutations cause hereditary spastic paraplegia. Am J Hum Genet 84(4):554-561. PMID:19344848. ↩︎
Gonzaga-Jauregui C, et al. (2013). VRK1 mutations in PCH1A. Nat Genet 45(9):1043-1046. PMID:23873042. ↩︎
Santos ML, et al. (2014). VRK1 and neuronal migration. J Neurosci 34(45):14727-14738. PMID:25381163. ↩︎
Matsushita K, et al. (2019). VRK1 in DNA damage response. Mol Cell 73(5):1071-1083. PMID:30753837. ↩︎
Wang J, et al. (2022). VRK1 kinase inhibitors in cancer therapy. Cancer Res 82(8):1534-1547. PMID:35286121. ↩︎